Caffeine urinary metabolite ratios as markers of enzyme activity: a theoretical assessment.
about
Cytochrome P450 isoform selectivity in human hepatic theobromine metabolismParkinson's disease and CYP1A2 activityCaffeine: cognitive and physical performance enhancer or psychoactive drug?Contribution of dihydrocodeine and dihydromorphine to analgesia following dihydrocodeine administration in man: a PK-PD modelling analysisVariability of cytochrome P450 1A2 activity over time in young and elderly healthy volunteersCaffeine based measures of CYP1A2 activity correlate with oral clearance of tacrine in patients with Alzheimer's disease.The effect of the CYP1A2 *1F mutation on CYP1A2 inducibility in pregnant women.NAT2 and CYP1A2 phenotyping with caffeine: head-to-head comparison of AFMU vs. AAMU in the urine metabolite ratios.Physiologically based modelling of inhibition of metabolism and assessment of the relative potency of drug and metabolite: dextromethorphan vs. dextrorphan using quinidine inhibitionDietary caffeine as a probe agent for assessment of cytochrome P4501A2 activity in random urine samples.Tacrine is not an ideal probe drug for measuring CYP1A2 activity in vivoPhenotypic polymorphism and gender-related differences of CYP1A2 activity in a Chinese populationThe effect of NAT2 genotype and gender on the metabolism of caffeine in nonsmoking subjects.Benzydamine N-oxidation as an index reaction reflecting FMO activity in human liver microsomes and impact of FMO3 polymorphisms on enzyme activity.Evaluation of flurbiprofen urinary ratios as in vivo indices for CYP2C9 activity.Prenatal caffeine assessment: fetal and maternal biomarkers or self-reported intake?Coffee intake, variants in genes involved in caffeine metabolism, and the risk of epithelial ovarian cancer.Assessment of CYP1A2 enzyme activity in relation to type-2 diabetes and habitual caffeine intake.CYP1A2, GSTM1, and GSTT1 polymorphisms and diet effects on CYP1A2 activity in a crossover feeding trial.Tolterodine does not affect the human in vivo metabolism of the probe drugs caffeine, debrisoquine and omeprazole.Functional significance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine.
P2860
Q24564968-01A6CEE0-B952-4AF8-B6B7-A589D7EEB1E3Q24564991-ED74940E-5FEB-4B38-8475-D7CF8C0B9B28Q28080581-4BE019EA-2967-4EA7-9779-A8B93DEC5EF5Q28343852-F077E7F7-75E6-4971-93A6-81C31B42DDDEQ28365919-0889DEBF-F7F0-4A21-BCDE-653214ACBB98Q35802571-0C15C783-3C2B-4BA6-B2B4-B9DC8232BDBDQ35804103-385F4670-DD9F-4E87-977C-DC3121546DABQ35825149-7646336D-052B-442E-B6AE-6C3E48715469Q35825657-01F9A697-A777-4529-AC01-E60A0C885D8FQ36053371-C65CF320-6416-4E53-8B4C-B399219F6114Q36053773-970228E6-19AE-44DB-AF46-C7F0C7230F0DQ36055051-D7B3D53E-CE46-45CF-B324-AE5E8B30FCF2Q36055087-A0B24E5E-5FAB-4AE2-BCC2-1C7C65A2944DQ36055351-954AAF6D-E448-4340-A5E2-240CF41F26FFQ36387998-62A1D89F-A2AE-460C-8FE0-749CCFF87EB6Q36511028-2481AB6E-21E4-46E3-BA0E-806DAB2E3F1BQ37218434-D39C79AC-F8C3-4B46-AE05-009958EB610DQ37315406-21B6BA45-AC18-4EBF-831E-F6206A5684F8Q37442320-BD0792CF-0F53-4110-90CD-BC656FAC5F09Q41591816-E0F2B7D0-A4D6-4DEE-A40F-DF13C5BEBAA5Q41593416-2F0C5B71-27FB-49CF-ACF1-B2CD5059E69C
P2860
Caffeine urinary metabolite ratios as markers of enzyme activity: a theoretical assessment.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Caffeine urinary metabolite ra ...... ity: a theoretical assessment.
@en
Caffeine urinary metabolite ra ...... ity: a theoretical assessment.
@nl
type
label
Caffeine urinary metabolite ra ...... ity: a theoretical assessment.
@en
Caffeine urinary metabolite ra ...... ity: a theoretical assessment.
@nl
prefLabel
Caffeine urinary metabolite ra ...... ity: a theoretical assessment.
@en
Caffeine urinary metabolite ra ...... ity: a theoretical assessment.
@nl
P2093
P1476
Caffeine urinary metabolite ra ...... vity: a theoretical assessment
@en
P2093
A Rostami-Hodjegan
G T Tucker
P R Jackson
S Nurminen
P304
P356
10.1097/00008571-199604000-00001
P577
1996-04-01T00:00:00Z